Update in geriatrics

Annals of Internal Medicine

Volumn 131, Issue 11, 1999, Pages 842-849

  Hall, William J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ACETYLSALICYLIC ACID; ALENDRONIC ACID; ALPHA TOCOPHEROL; APOLIPOPROTEIN E; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR; CALCIUM; COLECALCIFEROL; CONJUGATED ESTROGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DONEPEZIL; ESTROGEN; ETIDRONIC ACID; LIPID; MEDROXYPROGESTERONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYBUTYNIN; PARACETAMOL; PETHIDINE; PREMPAK; RALOXIFENE; RETINOL; SEROTONIN UPTAKE INHIBITOR; TACRINE; TAMOXIFEN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ACUTE HEART INFARCTION; ALZHEIMER DISEASE; BEHAVIOR THERAPY; BLOOD PRESSURE; BONE DENSITY; CLINICAL TRIAL; COGNITION; CONGESTIVE HEART FAILURE; DEMENTIA; EXERCISE; FALLING; FEEDBACK SYSTEM; GASTROINTESTINAL SYMPTOM; GENE; GENOTYPE; GERIATRICS; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; LIVER TOXICITY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PAIN; PRIORITY JOURNAL; RATING SCALE; REVIEW; URGE INCONTINENCE; VERTEBRA FRACTURE;

EID: 0033534081     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-131-11-199912070-00008     Document Type: Review

References (19)

1. Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R, et al. The APOE-∈4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 1998;279:751-5.
2. O'Hara R, Yesavage JA, Kraemer HC, Mauricio M, Friedman LF, Murphy GM. The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults. J Am Geriatr Soc. 1998;46: 1493-8.
3. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology. 1998;50:136-45.
4. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy n postmenopausal women: effects on cognitive function and dementia. JAMA. 1998;279: 688-95.
5. Shaywitz SE, Shaywitz BA, Pugh KR, Fulbright RK, Skudlarski P, Mencl WE, et al. Effect of estrogen activation patterns in postmenopausal women during working memory tasks. JAMA. 1999;281:1197-202.
6. Hosking D, Chilvers CE, Christiansen C, Ravn P, Wasnich R, Ross P, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age N Engl J Med. 1998;338:485-92.
7. McClung M, Clemmesen B, Daifotis A, Gilchrist NL, Eisman J, Weinstein RS, et al. Alendronate prevents postmenopausal bone loss in women without osteoporosis. A double-blind, randomized, controlled trial. Alendronate Osteoporosis Prevention Study Group. Ann Intern Med. 1998;128:253-61.
8. Hulley S, Grady D, Bush T, Furtberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-13.
9. Havranek EP, Abrams F, Stevens E, Parker E. Determinants of mortality in elderly patients with heart failure: the role of angiotensin-converting enzyme inhibitors. Arch Intern Med. 1998;158:2024-8.
10. Mendelson G, Aronow WS. Underutilization of angiotensin-converting enzyme inhibitors in older patients with Q-wave antenor myocardial infarction in an academic hospital-based geriatrics practice. J Am Geriatr Soc. 1998;46: 751-2.
11. Lemaitre RN, Furberg CD, Newman AB, Hulley SB, Gordon DJ, Gottdiener JS, et al. Tirre trends in the use of cholesterol-lowering agents in older adults: the Cardiovascular Health Study. Arch Intern Med. 1998;158: 1761-8.
12. Aronow WS. Underutilization of aspirin in older patients with prior myocardial infarction at the time of admission to a nursing home. J Am Geriatr Soc. 1998;46:615-6.
13. Brass LM, Krumholz HM, Scinto JD, Mathur D, Radford M. Warfarin use following ischemic stroke among Medicare patients with atrial fibrillation. Arch Intern Med. 1998;158:2093-100.
14. Pereira MA, Kriska AM, Day RD, Cauley JA, LaPorte RE, Kuller LH. A randomized walking trial in postmenopausal women: effects on physical activity and health 10 years later. Arch Intern Med. 1998;158:1695-701.
15. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998;338:1-7.
16. Hakim AA, Petrovitch H, Burchfiel CM, Ross GW, Rodriquez BL, White LR, et al. Effects of walking on mortality among nonsmoking retired men. N Engl J Med. 1998;338:94-9.
17. Rowe JW, Kahn RL. Successful Aging. New York: Pantheon Pr; 1998.
18. Liu B, Anderson G, Mittman N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet. 1988;351:1303-7.
19. Fantl JA, Newman DK, Colling J, DeLancey JO, Keeys C, Loughery L, et al. Urinary Incontinence in Adults: Acute and Chronic Management. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; March 1996. AHCPR publication 96-0682. Clinical Practice Guideline no. 2, 1996 Update.